Anne O’Brien

Statistics

Publications

Citations

111

H-Index

Active since

2000

Affiliations

IDELIX Software (Canada)(Current)

Anne O’Brien is an author at IDELIX Software (Canada) specializing in medicine, serotonergic pharmacology, and 5-hydroxytryptamine receptor pharmacology.

ORCID

Publications per year

2000–2018

Publications

Pyrrolo[3,2,1- ij ]quinoline derivatives, a 5-HT 2c receptor agonist with selectivity over the 5-HT 2a receptor: potential therapeutic applications for epilepsy and obesity

Methvin Isaac, Abdelmalik Slassi, Anne O’Brien et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 40 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +9

Recent progress in 5-HT<sub>6</sub>receptor antagonists for the treatment of CNS diseases

Abdelmalik Slassi, Methvin Isaac, Anne O’Brien · Expert Opinion on Therapeutic Patents · 2002 · 35 citations

Medicine, Neuroscience, Pharmacology +16

5-Alkyltryptamine derivatives as highly selective and potent 5-HT1D receptor agonists

Abdelmalik Slassi, Louise Edwards, Anne O’Brien et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 14 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

1-(Bicyclopiperazinyl)ethylindoles and 1-(homopiperazinyl)ethyl-indoles as highly selective and potent 5-HT7 receptor ligands

Methvin Isaac, Tao Xin, Anne O’Brien et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 11 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

Support available for and perceived priorities of people with polymyalgia rheumatica and giant cell arteritis: results of the PMRGCAuk members’ survey 2017

Sara Müller, Anne O’Brien, Toby Helliwell et al. · Clinical Rheumatology · 2018 · 11 citations · Full text

Medicine, Internal Medicine, Health Services Research +7

1–5 of 5